(SSNC) SS&C Technologies Holdings - NASDAQ
Sector: Technology | Industry: Software - Application | Exchange: NASDAQ (USA) | Market Cap: 16.837m USD | Total Return: -14.3% in 12m
Avg Turnover: 179M
EPS Trend: -21.1%
Qual. Beats: 0
Rev. Trend: 99.7%
Qual. Beats: 4
Warnings
No concerns identified
Tailwinds
No distinct edge detected
SS&C Technologies Holdings, Inc. provides mission-critical software and outsourcing services to the global financial services and healthcare sectors. The company operates a comprehensive technology stack that manages the full investment lifecycle, including front-office trading, middle-office portfolio management, and back-office accounting and regulatory compliance.
The business model relies heavily on software-enabled services, where SS&C hosts its proprietary applications and provides the necessary operational staff to manage client data. This approach creates high switching costs and recurring revenue streams, which are characteristic of the specialized application software industry. In addition to finance, the firm provides claims adjudication and health outcomes optimization solutions to the healthcare industry.
Investors may find it useful to examine ValueRay for further data on the companys historical performance.
Founded in 1986 and headquartered in Windsor, Connecticut, SS&C maintains a global footprint with operations across the Americas, EMEA, and Asia Pacific. Its service offerings include specialized platforms such as GlobeOp for fund administration and Virtual Data Rooms for secure information sharing during corporate transactions.
- Alternative investment fund growth drives demand for SS&C GlobeOp administration services
- High recurring revenue from software-enabled services provides stability during market volatility
- Strategic acquisitions and integration efficiency determine long-term margin and earnings growth
- Rising interest rates impact debt servicing costs for highly leveraged balance sheet
- Financial services consolidation reduces potential client base for specialized back-office software
| Net Income: 810.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 1.37 > 1.0 |
| NWC/Revenue: 7.31% < 20% (prev 10.13%; Δ -2.82% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.78b > Net Income 810.0m |
| Net Debt (7.42b) to EBITDA (2.16b): 3.44 < 3 |
| Current Ratio: 1.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (247.6m) vs 12m ago -2.86% < -2% |
| Gross Margin: 48.03% > 18% (prev 48.71%; Δ -0.68% > 0.5%) |
| Asset Turnover: 31.45% > 50% (prev 29.21%; Δ 2.24% > 0%) |
| Interest Coverage Ratio: 3.38 > 6 (EBIT TTM 1.44b / Interest Expense TTM 426.5m) |
| A: 0.02 (Total Current Assets 5.34b - Total Current Liabilities 4.88b) / Total Assets 20.3b |
| B: 0.21 (Retained Earnings 4.34b / Total Assets 20.3b) |
| C: 0.07 (EBIT TTM 1.44b / Avg Total Assets 20.4b) |
| D: 0.51 (Book Value of Equity 6.84b / Total Liabilities 13.4b) |
| Altman-Z'' = 1.86 = BBB |
| DSRI: 0.79 (Receivables 4.69b/5.56b, Revenue 6.41b/5.96b) |
| GMI: 1.01 (GM 48.71% / 48.03%) |
| AQI: 1.06 (AQ_t 0.71 / AQ_t-1 0.67) |
| SGI: 1.07 (Revenue 6.41b / 5.96b) |
| TATA: -0.05 (NI 810.0m - CFO 1.78b) / TA 20.3b) |
| Beneish M = -3.10 (Cap -4..+1) = AA |
As of June 10, 2026, the stock is trading at USD 68.69 with a total of 2,223,730 shares traded.
Over the past week, the price has changed by +0.69%,
over one month by +2.87%,
over three months by -7.30% and
over the past year by -14.25%.
SS&C Technologies Holdings has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy SSNC.
- StrongBuy: 6
- Buy: 4
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 94.8 | 38% |
P/E Trailing = 21.7112
P/E Forward = 10.1937
P/S = 2.6285
P/B = 2.4424
P/EG = 0.7182
Revenue TTM = 6.41b USD
EBIT TTM = 1.44b USD
EBITDA TTM = 2.16b USD
Long Term Debt = 7.32b USD (from longTermDebt, last quarter)
Short Term Debt = 110.0m USD (from shortTermDebt, last quarter)
Debt = 7.84b USD (from shortLongTermDebtTotal, last quarter) + Leases 202.9m
Net Debt = 7.42b USD (calculated: Debt 7.84b - CCE 420.9m)
Enterprise Value = 24.3b USD (16.8b + Debt 7.84b - CCE 420.9m)
Interest Coverage Ratio = 3.38 (Ebit TTM 1.44b / Interest Expense TTM 426.5m)
EV/FCF = 14.18x (Enterprise Value 24.3b / FCF TTM 1.71b)
FCF Yield = 7.05% (FCF TTM 1.71b / Enterprise Value 24.3b)
FCF Margin = 26.69% (FCF TTM 1.71b / Revenue TTM 6.41b)
Net Margin = 12.65% (Net Income TTM 810.0m / Revenue TTM 6.41b)
Gross Margin = 48.03% ((Revenue TTM 6.41b - Cost of Revenue TTM 3.33b) / Revenue TTM)
Gross Margin QoQ = 48.68% (prev 47.77%)
Tobins Q-Ratio = 1.19 (Enterprise Value 24.3b / Total Assets 20.3b)
Interest Expense / Debt = 5.44% (Interest Expense 426.5m / Debt 7.84b)
Taxrate = 20.15% (204.8m / 1.02b)
NOPAT = 1.15b (EBIT 1.44b * (1 - 20.15%))
Current Ratio = 1.10 (Total Current Assets 5.34b / Total Current Liabilities 4.88b)
Debt / Equity = 1.15 (Debt 7.84b / totalStockholderEquity, last quarter 6.84b)
Debt / EBITDA = 3.44 (Net Debt 7.42b / EBITDA 2.16b)
Debt / FCF = 4.34 (Net Debt 7.42b / FCF TTM 1.71b)
Total Stockholder Equity = 6.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.98% (Net Income 810.0m / Total Assets 20.3b)
RoE = 11.74% (Net Income TTM 810.0m / Total Stockholder Equity 6.90b)
RoCE = 10.15% (EBIT 1.44b / Capital Employed (Equity 6.90b + L.T.Debt 7.32b))
RoIC = 7.56% (NOPAT 1.15b / Invested Capital 15.2b)
WACC = 7.30% (E(16.8b)/V(24.7b) * Re(8.67%) + D(7.84b)/V(24.7b) * Rd(5.44%) * (1-Tc(0.20)))
Discount Rate = 8.67% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -24.44 | Cagr: -0.80%
[DCF] Terminal Value 77.97% ; FCFF base≈1.60b ; Y1≈1.84b ; Y5≈2.70b
[DCF] Fair Price = 138.0 (EV 40.6b - Net Debt 7.42b = Equity 33.2b / Shares 240.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -21.11 | EPS CAGR: -1.93% | SUE: 0.42 | # QB: 0
Revenue Correlation: 99.73 | Revenue CAGR: 6.59% | SUE: 1.77 | # QB: 4
EPS current Quarter (2026-06-30): EPS=1.68 | Chg30d=+0.00% | Revisions=+33% | Analysts=9
EPS next Quarter (2026-09-30): EPS=1.72 | Chg30d=+0.00% | Revisions=-9% | Analysts=9
EPS current Year (2026-12-31): EPS=6.89 | Chg30d=+0.00% | Revisions=+45% | GrowthEPS=+12.2% | GrowthRev=+7.5%
EPS next Year (2027-12-31): EPS=7.50 | Chg30d=+0.00% | Revisions=+20% | GrowthEPS=+8.8% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: +45%